Literature DB >> 8659599

Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease.

Y Oshima1, S Harino, Y Hara, Y Tano.   

Abstract

PURPOSE: To report the indocyanine green angiographic findings associated with Vogt-Koyanagi-Harada disease and compare them with fluorescein angiographic findings and monochromatic scanning laser images.
METHODS: In a prospective study, indocyanine green angiography, by scanning laser ophthalmoscopy or infrared fundus photography, was performed in ten consecutive patients (20 eyes) with Vogt-Koyanagi-Harada disease during the acute stage before and recovery stage after corticosteroid treatment. Findings were compared with fluorescein angiographic features and monochromatic scanning laser imaging.
RESULTS: During the acute stage of the disease, indocyanine green angiography disclosed a dark background in the early phase and multiple, non-uniform hypofluorescent lesions in the midphases. Lesions were more numerous and extensive than areas either of serous retinal detachment on monochromatic scanning laser imaging or of punctate hyperfluorescence on fluorescein angiography. During the recovery stage, the abnormal dark background on indocyanine green angiography at initial examination resolved, with choroidal vessels visible in all cases, but nonuniform hypofluorescent lesions persisted in most eyes. Fluorescein angiography disclosed hypofluorescent patchy areas, and confocal infrared laser imaging showed some bright reflective lesions in three patients with especially severe clinical symptoms. On final examination after an average of 17.7 months, both angiographies still disclosed abnormal findings in these three patients.
CONCLUSIONS: Indocyanine green angiographic findings suggest that choroidal inflammation may cause a transient choroidal circulatory disturbance during the acute stage of Vogt-Koyanagi-Harada disease. In more severe cases, this dysfunction may secondarily damage the retinal pigment epithelium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8659599     DOI: 10.1016/s0002-9394(14)71964-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  Choroidal dye filling velocity in patients with Vogt-Koyanagi-Harada disease.

Authors:  Yuki Mawatari; Akira Hirata; Mikiko Fukushima; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

2.  Usefulness of anterior chamber depth measurement for efficacy assessment of steroid pulse therapy in patients with Vogt-Koyanagi-Harada disease.

Authors:  Tomohiro Otsuki; Kimiya Shimizu; Akihito Igarashi; Kazutaka Kamiya
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

3.  Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients.

Authors:  Masaru Miyanaga; Tatsushi Kawaguchi; Kazunori Miyata; Shintaro Horie; Manabu Mochizuki; Carl P Herbort
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

4.  Subtraction ICG angiography in Harada's disease.

Authors:  T Kohno; T Miki; K Shiraki; K Kano; M Matsushita; K Hayashi; J J De Laey
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

5.  Age-related scattered hypofluorescent spots on late-phase indocyanine green angiograms.

Authors:  K Shiraki; M Moriwaki; T Kohno; N Yanagihara; T Miki
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

6.  Lymphocytic leukemia presenting as acute Vogt-Koyanagi-Harada disease.

Authors:  Waseem M AlZamil
Journal:  Saudi J Ophthalmol       Date:  2013-08-03

7.  Clinical findings in unilateral acute idiopathic maculopathy: new findings in acute idiopathic maculopathy.

Authors:  Hiroshi Haruta; Miki Sawa; Yoshitsugu Saishin; Nobuyuki Ohguro; Yasuo Tano
Journal:  Int Ophthalmol       Date:  2009-01-29       Impact factor: 2.031

8.  Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome.

Authors:  A A Okada; T Mizusawa; J Sakai; M Usui
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

9.  Acute lymphoblastic leukemia manifesting as acute Vogt-Koyanagi-Harada disease.

Authors:  Hee Kyung Yang; Hyeong Gon Yu
Journal:  Korean J Ophthalmol       Date:  2009-12-04

10.  Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.

Authors:  Tatsushi Kawaguchi; Shintaro Horie; Nadia Bouchenaki; Kyoko Ohno-Matsui; Manabu Mochizuki; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2009-01-17       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.